CRISPR Therapeutics (CRSP) Fails to deliver data

Key failure to deliver metrics for CRISPR Therapeutics:

• Last SEC data release: 2024-11-29
• Last 15 days FTD volume: NZ$8.89 M
• Last 3 months FTD volume: NZ$48.54 M
• Last year FTD volume: NZ$48.54 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for CRISPR Therapeutics (CRSP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for CRISPR Therapeutics (CRSP) - since 2016

CRISPR Therapeutics (CRSP) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
ORIC Pharmaceuticals ORIC	NZ$1 M	NZ$6 M	🇺🇸 USA